Chapter 11 · Filed Mar 27, 2023
The Codiak BioSciences Chapter 11 cases were dismissed on July 31, 2023, ending the court-supervised restructuring and leaving no active Chapter 11 financing authority. The case was a monetization-focused wind-down rather than a going-concern reorganization.
Updated Sep 5, 6:53 AM ET
Affidavit/Declaration of Service re: Certification of Counsel and Request for Entry of an Order Dismissing Chapter 11 Cases (Docket No. 318), Order (I) Dismissing Debtors Chapter 11 Cases and (II) Granting Related Relief (Docket No. 319). Filed by Stretto. (related document(s)[318], [319]) (Betance, Sheryl)
Dkt. 321 · Aug 7, 2023
Affidavit/Declaration of Service re: Omnibus Order Approving Final Fee Applications of the Debtors Professionals (Docket No. 314), Notice of Amended Agenda of Matters Scheduled for Hearing on July 27, 2023 at 3:00 P.M. (ET) (Docket No. 315). Filed by Stretto. (related document(s)[314], [315]) (Betance, Sheryl)
Dkt. 320 · Jul 31, 2023
Chapter 11 Monthly Operating Report for the Month Ending: 07/31/2023 Filed by Codiak BioSciences, Inc.. (Attachments: # (1) Supplemental Documentation) (Justison, Elizabeth)
Dkt. 316 · Jul 31, 2023
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.